Zhongcong Xie, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics, Inhalation | 34 | 2023 | 573 | 8.180 |
Why?
|
| Isoflurane | 27 | 2023 | 384 | 6.510 |
Why?
|
| Methyl Ethers | 9 | 2017 | 196 | 2.890 |
Why?
|
| Caspase 3 | 13 | 2014 | 731 | 2.420 |
Why?
|
| tau Proteins | 10 | 2023 | 2145 | 1.960 |
Why?
|
| Amyloid beta-Peptides | 21 | 2016 | 3912 | 1.900 |
Why?
|
| Cognition Disorders | 15 | 2016 | 3985 | 1.870 |
Why?
|
| Caspases | 7 | 2014 | 881 | 1.430 |
Why?
|
| Deoxyglucose | 3 | 2016 | 333 | 1.310 |
Why?
|
| Anesthesia | 6 | 2023 | 1596 | 1.280 |
Why?
|
| Amyloid beta-Protein Precursor | 12 | 2011 | 1116 | 1.180 |
Why?
|
| Delirium | 11 | 2024 | 1696 | 1.180 |
Why?
|
| Alzheimer Disease | 18 | 2023 | 8758 | 1.070 |
Why?
|
| Propofol | 4 | 2023 | 608 | 1.030 |
Why?
|
| Anesthetics, General | 3 | 2012 | 152 | 1.020 |
Why?
|
| Antimetabolites | 2 | 2016 | 129 | 0.970 |
Why?
|
| Apoptosis | 13 | 2013 | 9528 | 0.860 |
Why?
|
| Amyloid Precursor Protein Secretases | 9 | 2014 | 614 | 0.840 |
Why?
|
| Mice, Inbred C57BL | 26 | 2024 | 22381 | 0.810 |
Why?
|
| Enzyme Activation | 14 | 2014 | 3588 | 0.790 |
Why?
|
| Interleukin-6 | 8 | 2022 | 3233 | 0.790 |
Why?
|
| Neurons | 13 | 2021 | 9524 | 0.730 |
Why?
|
| Mitochondria | 6 | 2014 | 3683 | 0.710 |
Why?
|
| Postoperative Complications | 16 | 2024 | 15889 | 0.710 |
Why?
|
| Hippocampus | 9 | 2021 | 3786 | 0.710 |
Why?
|
| Olfaction Disorders | 1 | 2022 | 225 | 0.670 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2014 | 905 | 0.670 |
Why?
|
| Anesthetics | 3 | 2014 | 525 | 0.650 |
Why?
|
| Mice | 39 | 2024 | 82074 | 0.630 |
Why?
|
| Blood-Brain Barrier | 2 | 2022 | 1036 | 0.630 |
Why?
|
| Cytotoxins | 2 | 2016 | 154 | 0.590 |
Why?
|
| Learning | 5 | 2013 | 1761 | 0.570 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2012 | 302 | 0.560 |
Why?
|
| Microfluidics | 1 | 2022 | 674 | 0.560 |
Why?
|
| Memory | 5 | 2014 | 2210 | 0.560 |
Why?
|
| Mice, Transgenic | 11 | 2023 | 9564 | 0.550 |
Why?
|
| RNA Interference | 5 | 2006 | 2835 | 0.550 |
Why?
|
| Animals | 53 | 2024 | 169408 | 0.540 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2014 | 297 | 0.540 |
Why?
|
| Cognition | 7 | 2023 | 7080 | 0.540 |
Why?
|
| Locomotion | 1 | 2019 | 390 | 0.540 |
Why?
|
| Anesthesia, General | 3 | 2023 | 1189 | 0.530 |
Why?
|
| Blotting, Western | 12 | 2014 | 5035 | 0.530 |
Why?
|
| Neurofilament Proteins | 1 | 2018 | 337 | 0.510 |
Why?
|
| Protein Transport | 2 | 2021 | 1956 | 0.500 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2014 | 414 | 0.500 |
Why?
|
| Cytoprotection | 2 | 2014 | 200 | 0.480 |
Why?
|
| Hippocalcin | 1 | 2014 | 7 | 0.470 |
Why?
|
| Animals, Newborn | 5 | 2021 | 2695 | 0.470 |
Why?
|
| Brain | 13 | 2024 | 27476 | 0.470 |
Why?
|
| Gene Silencing | 3 | 2005 | 1505 | 0.450 |
Why?
|
| Aspartic Acid Endopeptidases | 3 | 2011 | 308 | 0.440 |
Why?
|
| Membrane Proteins | 5 | 2014 | 7885 | 0.440 |
Why?
|
| Synapses | 2 | 2013 | 1766 | 0.440 |
Why?
|
| Inflammation Mediators | 3 | 2017 | 1890 | 0.440 |
Why?
|
| Cell Line, Tumor | 19 | 2016 | 17174 | 0.440 |
Why?
|
| Prenatal Injuries | 1 | 2013 | 13 | 0.430 |
Why?
|
| Maze Learning | 5 | 2017 | 484 | 0.430 |
Why?
|
| Nerve Tissue Proteins | 5 | 2013 | 4415 | 0.430 |
Why?
|
| Ubiquitination | 1 | 2017 | 1010 | 0.420 |
Why?
|
| Nootropic Agents | 1 | 2014 | 159 | 0.410 |
Why?
|
| Signal Transduction | 6 | 2021 | 23652 | 0.400 |
Why?
|
| Phosphorylation | 6 | 2023 | 8317 | 0.390 |
Why?
|
| Nitrous Oxide | 2 | 2009 | 166 | 0.380 |
Why?
|
| Inflammation | 4 | 2021 | 10869 | 0.380 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 10 | 2021 | 3814 | 0.370 |
Why?
|
| Peptide Fragments | 3 | 2013 | 5150 | 0.370 |
Why?
|
| Ascorbic Acid | 1 | 2014 | 658 | 0.370 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 1320 | 0.370 |
Why?
|
| Preoperative Period | 1 | 2013 | 565 | 0.370 |
Why?
|
| Pain | 3 | 2017 | 5100 | 0.360 |
Why?
|
| Glioma | 5 | 2014 | 3532 | 0.360 |
Why?
|
| Testosterone | 1 | 2021 | 2494 | 0.360 |
Why?
|
| Random Allocation | 5 | 2017 | 2396 | 0.360 |
Why?
|
| Neuroprotective Agents | 2 | 2014 | 958 | 0.350 |
Why?
|
| Hemoglobins | 1 | 2016 | 1531 | 0.340 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 627 | 0.330 |
Why?
|
| Encephalitis | 1 | 2013 | 441 | 0.320 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2023 | 1048 | 0.320 |
Why?
|
| Neural Stem Cells | 2 | 2013 | 895 | 0.320 |
Why?
|
| Disease Models, Animal | 11 | 2021 | 18366 | 0.310 |
Why?
|
| Endocytosis | 1 | 2013 | 959 | 0.310 |
Why?
|
| Anesthetics, Intravenous | 1 | 2011 | 397 | 0.310 |
Why?
|
| Cytosol | 2 | 2009 | 886 | 0.310 |
Why?
|
| Age Factors | 7 | 2020 | 18454 | 0.300 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 1190 | 0.300 |
Why?
|
| Reactive Oxygen Species | 5 | 2014 | 2149 | 0.290 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1143 | 0.280 |
Why?
|
| Memantine | 1 | 2008 | 111 | 0.280 |
Why?
|
| Neurogenesis | 1 | 2013 | 865 | 0.280 |
Why?
|
| Aging | 6 | 2024 | 8765 | 0.250 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2010 | 1966 | 0.250 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2011 | 612 | 0.240 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 1027 | 0.240 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2006 | 389 | 0.230 |
Why?
|
| C-Reactive Protein | 4 | 2021 | 3858 | 0.230 |
Why?
|
| Adenosine Triphosphate | 3 | 2015 | 2003 | 0.230 |
Why?
|
| Humans | 63 | 2024 | 768887 | 0.230 |
Why?
|
| Transfection | 4 | 2006 | 5763 | 0.230 |
Why?
|
| Hypocapnia | 1 | 2004 | 38 | 0.230 |
Why?
|
| Microglia | 2 | 2024 | 1376 | 0.230 |
Why?
|
| Endopeptidases | 2 | 2005 | 764 | 0.220 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 1665 | 0.220 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2014 | 4356 | 0.210 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2013 | 2541 | 0.210 |
Why?
|
| Bacteroidetes | 1 | 2023 | 84 | 0.210 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2013 | 1421 | 0.210 |
Why?
|
| Glucose | 1 | 2014 | 4352 | 0.210 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2013 | 1405 | 0.200 |
Why?
|
| Surgical Procedures, Operative | 1 | 2014 | 1941 | 0.200 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 2 | 2014 | 170 | 0.190 |
Why?
|
| Cell Hypoxia | 3 | 2011 | 662 | 0.190 |
Why?
|
| Neuropeptides | 1 | 2006 | 951 | 0.180 |
Why?
|
| Male | 28 | 2024 | 365249 | 0.170 |
Why?
|
| Pain Threshold | 2 | 2014 | 606 | 0.170 |
Why?
|
| Serine | 1 | 2023 | 831 | 0.160 |
Why?
|
| Calcium | 2 | 2014 | 5792 | 0.160 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2006 | 2911 | 0.160 |
Why?
|
| Dexmedetomidine | 1 | 2023 | 320 | 0.160 |
Why?
|
| Cerebral Cortex | 2 | 2014 | 5834 | 0.160 |
Why?
|
| Perioperative Period | 1 | 2020 | 252 | 0.150 |
Why?
|
| Proteomics | 3 | 2023 | 3913 | 0.150 |
Why?
|
| Carrier Proteins | 3 | 2007 | 4940 | 0.150 |
Why?
|
| Sleep | 2 | 2024 | 4820 | 0.150 |
Why?
|
| Female | 28 | 2023 | 397464 | 0.150 |
Why?
|
| Epistasis, Genetic | 1 | 2020 | 353 | 0.140 |
Why?
|
| Pulmonary Artery | 1 | 2006 | 1945 | 0.140 |
Why?
|
| Aged | 18 | 2023 | 171790 | 0.140 |
Why?
|
| Carbamates | 2 | 2009 | 192 | 0.140 |
Why?
|
| Tauopathies | 1 | 2021 | 328 | 0.140 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 3714 | 0.140 |
Why?
|
| Fear | 3 | 2014 | 1494 | 0.140 |
Why?
|
| Drug Synergism | 2 | 2015 | 1762 | 0.140 |
Why?
|
| RNA, Small Interfering | 5 | 2006 | 3433 | 0.140 |
Why?
|
| Dipeptides | 2 | 2009 | 386 | 0.140 |
Why?
|
| Psychomotor Agitation | 1 | 2019 | 307 | 0.130 |
Why?
|
| Kidney Neoplasms | 1 | 2013 | 4300 | 0.130 |
Why?
|
| Neuropsychological Tests | 3 | 2016 | 7148 | 0.130 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2018 | 251 | 0.130 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 6512 | 0.130 |
Why?
|
| Ubiquinone | 2 | 2015 | 183 | 0.130 |
Why?
|
| Presenilin-1 | 3 | 2005 | 665 | 0.130 |
Why?
|
| Cell Survival | 3 | 2014 | 5794 | 0.130 |
Why?
|
| Cells, Cultured | 7 | 2017 | 19023 | 0.130 |
Why?
|
| Prospective Studies | 10 | 2024 | 54950 | 0.120 |
Why?
|
| Nitro Compounds | 1 | 2015 | 74 | 0.120 |
Why?
|
| Lipids | 1 | 2006 | 3345 | 0.120 |
Why?
|
| Behavior, Animal | 2 | 2014 | 1879 | 0.120 |
Why?
|
| Escape Reaction | 1 | 2014 | 57 | 0.120 |
Why?
|
| Freund's Adjuvant | 1 | 2014 | 144 | 0.120 |
Why?
|
| Species Specificity | 2 | 2010 | 2419 | 0.120 |
Why?
|
| Proteome | 2 | 2022 | 1891 | 0.110 |
Why?
|
| Propionates | 1 | 2015 | 180 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2021 | 14485 | 0.110 |
Why?
|
| Flumazenil | 1 | 2014 | 84 | 0.110 |
Why?
|
| Apolipoproteins E | 1 | 2020 | 1461 | 0.110 |
Why?
|
| Tumor Cells, Cultured | 2 | 2011 | 6131 | 0.110 |
Why?
|
| GABA Antagonists | 1 | 2014 | 119 | 0.110 |
Why?
|
| Neuregulin-1 | 1 | 2014 | 136 | 0.110 |
Why?
|
| Carnitine | 1 | 2015 | 253 | 0.110 |
Why?
|
| GABA Agonists | 1 | 2014 | 106 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2013 | 110 | 0.110 |
Why?
|
| Amyloidogenic Proteins | 1 | 2014 | 154 | 0.110 |
Why?
|
| Hyperalgesia | 1 | 2017 | 527 | 0.110 |
Why?
|
| Physician Executives | 1 | 2014 | 140 | 0.100 |
Why?
|
| Ibuprofen | 1 | 2014 | 229 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 4 | 2010 | 3775 | 0.100 |
Why?
|
| Eating | 1 | 2019 | 1542 | 0.100 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 5803 | 0.100 |
Why?
|
| Dementia | 1 | 2006 | 2741 | 0.100 |
Why?
|
| Peptide Hydrolases | 2 | 2005 | 610 | 0.100 |
Why?
|
| Lithium | 1 | 2014 | 600 | 0.090 |
Why?
|
| Immunohistochemistry | 4 | 2012 | 11119 | 0.090 |
Why?
|
| Conditioning, Classical | 1 | 2013 | 370 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2010 | 4148 | 0.090 |
Why?
|
| Nanotechnology | 1 | 2016 | 714 | 0.090 |
Why?
|
| China | 2 | 2019 | 2395 | 0.090 |
Why?
|
| Anesthesiology | 2 | 2014 | 1137 | 0.090 |
Why?
|
| Accreditation | 1 | 2014 | 477 | 0.090 |
Why?
|
| Body Weight | 2 | 2019 | 4628 | 0.090 |
Why?
|
| Drug Hypersensitivity | 1 | 2019 | 923 | 0.090 |
Why?
|
| Activities of Daily Living | 1 | 2019 | 2433 | 0.090 |
Why?
|
| Caspase 9 | 1 | 2009 | 184 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2013 | 725 | 0.080 |
Why?
|
| Cytochromes c | 1 | 2009 | 173 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2011 | 10778 | 0.080 |
Why?
|
| Specialties, Surgical | 1 | 2014 | 393 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 1169 | 0.080 |
Why?
|
| Enzyme Inhibitors | 2 | 2009 | 3724 | 0.080 |
Why?
|
| Anesthesia, Spinal | 1 | 2011 | 282 | 0.080 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2009 | 282 | 0.080 |
Why?
|
| Geriatric Assessment | 1 | 2016 | 1422 | 0.080 |
Why?
|
| Clioquinol | 1 | 2008 | 23 | 0.080 |
Why?
|
| beta Catenin | 1 | 2013 | 1047 | 0.080 |
Why?
|
| Cytokines | 2 | 2024 | 7453 | 0.080 |
Why?
|
| Neuroblastoma | 1 | 2016 | 1266 | 0.070 |
Why?
|
| Cell Line | 2 | 2012 | 15603 | 0.070 |
Why?
|
| Abdomen | 1 | 2014 | 1137 | 0.070 |
Why?
|
| Administration, Inhalation | 1 | 2010 | 1169 | 0.070 |
Why?
|
| Presenilins | 1 | 2007 | 51 | 0.070 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2006 | 46 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2016 | 2258 | 0.070 |
Why?
|
| Antioxidants | 1 | 2015 | 1673 | 0.070 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 426 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2022 | 3683 | 0.070 |
Why?
|
| Phenotype | 1 | 2024 | 16735 | 0.070 |
Why?
|
| Protein Multimerization | 1 | 2011 | 968 | 0.070 |
Why?
|
| Vitamins | 1 | 2015 | 1638 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 1973 | 0.060 |
Why?
|
| Cell Count | 1 | 2010 | 1833 | 0.060 |
Why?
|
| Mutation | 3 | 2005 | 30266 | 0.060 |
Why?
|
| Cell Cycle Proteins | 2 | 2007 | 3450 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2023 | 8200 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4593 | 0.060 |
Why?
|
| Time Factors | 3 | 2014 | 40266 | 0.060 |
Why?
|
| Plaque, Amyloid | 1 | 2009 | 769 | 0.060 |
Why?
|
| Hypercapnia | 1 | 2006 | 260 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 1813 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2014 | 2941 | 0.060 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2011 | 1143 | 0.060 |
Why?
|
| Risk Factors | 6 | 2023 | 74971 | 0.060 |
Why?
|
| Electroporation | 1 | 2005 | 238 | 0.060 |
Why?
|
| Research Design | 1 | 2020 | 6213 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2015 | 2905 | 0.050 |
Why?
|
| Rats | 6 | 2023 | 23847 | 0.050 |
Why?
|
| Pulmonary Circulation | 1 | 2006 | 744 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2005 | 687 | 0.050 |
Why?
|
| Protein Binding | 2 | 2006 | 9344 | 0.050 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2023 | 71 | 0.050 |
Why?
|
| Pulmonary Alveoli | 1 | 2006 | 665 | 0.050 |
Why?
|
| Linear Models | 1 | 2013 | 5890 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 1408 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2011 | 6242 | 0.050 |
Why?
|
| Boston | 2 | 2016 | 9375 | 0.050 |
Why?
|
| Wound Healing | 1 | 2014 | 2815 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 6320 | 0.050 |
Why?
|
| Anesthesia, Local | 1 | 2005 | 279 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2007 | 696 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 2635 | 0.050 |
Why?
|
| Gases | 1 | 2023 | 204 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2008 | 1194 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2005 | 930 | 0.050 |
Why?
|
| Actins | 1 | 2009 | 2065 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2006 | 1149 | 0.050 |
Why?
|
| Exons | 2 | 2006 | 2395 | 0.050 |
Why?
|
| Lidocaine | 1 | 2005 | 546 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 18065 | 0.050 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 59738 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2422 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2012 | 5905 | 0.050 |
Why?
|
| Oxygen | 1 | 2012 | 4273 | 0.040 |
Why?
|
| Neuroglia | 1 | 2006 | 960 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 2023 | 563 | 0.040 |
Why?
|
| Case-Control Studies | 3 | 2023 | 22294 | 0.040 |
Why?
|
| Indoles | 2 | 2023 | 1836 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2012 | 1891 | 0.040 |
Why?
|
| Cadherins | 1 | 2005 | 906 | 0.040 |
Why?
|
| Child Development | 1 | 2012 | 2337 | 0.040 |
Why?
|
| Drosophila | 1 | 2007 | 1513 | 0.040 |
Why?
|
| Pneumonectomy | 1 | 2006 | 1159 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 2488 | 0.040 |
Why?
|
| Age of Onset | 1 | 2006 | 3346 | 0.040 |
Why?
|
| Disease Progression | 2 | 2019 | 13677 | 0.040 |
Why?
|
| Progesterone | 1 | 2023 | 752 | 0.040 |
Why?
|
| Triglycerides | 1 | 2006 | 2464 | 0.040 |
Why?
|
| Anesthetics, Local | 1 | 2005 | 1004 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2007 | 1134 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2011 | 8742 | 0.040 |
Why?
|
| Parkinson Disease | 1 | 2012 | 2896 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2007 | 1712 | 0.040 |
Why?
|
| Leadership | 1 | 2007 | 1396 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2004 | 2674 | 0.030 |
Why?
|
| Pregnancy | 3 | 2013 | 30175 | 0.030 |
Why?
|
| Estradiol | 1 | 2023 | 1952 | 0.030 |
Why?
|
| Organoplatinum Compounds | 1 | 2017 | 408 | 0.030 |
Why?
|
| General Surgery | 1 | 2007 | 1722 | 0.030 |
Why?
|
| Apolipoprotein E4 | 1 | 2020 | 712 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 13699 | 0.030 |
Why?
|
| Middle Aged | 4 | 2013 | 223740 | 0.030 |
Why?
|
| Injections, Intraventricular | 1 | 2014 | 227 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2024 | 41800 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 1 | 2014 | 239 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2014 | 5956 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2014 | 276 | 0.030 |
Why?
|
| Motor Activity | 2 | 2014 | 2722 | 0.030 |
Why?
|
| Parvalbumins | 1 | 2014 | 261 | 0.030 |
Why?
|
| Deoxyuridine | 1 | 2011 | 34 | 0.020 |
Why?
|
| Propidium | 1 | 2011 | 42 | 0.020 |
Why?
|
| Models, Biological | 1 | 2008 | 9499 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 26394 | 0.020 |
Why?
|
| Orthopedic Procedures | 1 | 2021 | 1280 | 0.020 |
Why?
|
| Prevalence | 2 | 2019 | 15875 | 0.020 |
Why?
|
| Intermediate Filament Proteins | 1 | 2011 | 262 | 0.020 |
Why?
|
| Staurosporine | 1 | 2011 | 241 | 0.020 |
Why?
|
| Efficiency | 1 | 2014 | 480 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2011 | 412 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 9549 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3438 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2011 | 286 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2475 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 36541 | 0.020 |
Why?
|
| Interneurons | 1 | 2014 | 593 | 0.020 |
Why?
|
| Culture Media | 1 | 2011 | 898 | 0.020 |
Why?
|
| Carcinogens | 1 | 2011 | 453 | 0.020 |
Why?
|
| Coloring Agents | 1 | 2011 | 564 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2012 | 42684 | 0.020 |
Why?
|
| Alleles | 1 | 2020 | 6901 | 0.020 |
Why?
|
| Phenols | 1 | 2012 | 523 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 813 | 0.020 |
Why?
|
| Lung | 1 | 2006 | 10097 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39394 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2010 | 2173 | 0.020 |
Why?
|
| Length of Stay | 1 | 2021 | 6525 | 0.020 |
Why?
|
| Haplorhini | 1 | 2007 | 524 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2017 | 3585 | 0.020 |
Why?
|
| Massachusetts | 1 | 2019 | 8888 | 0.020 |
Why?
|
| Biotinylation | 1 | 2006 | 185 | 0.020 |
Why?
|
| Cricetinae | 1 | 2010 | 2423 | 0.020 |
Why?
|
| Cell Death | 1 | 2011 | 1682 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2006 | 825 | 0.020 |
Why?
|
| Absorption | 1 | 2005 | 243 | 0.020 |
Why?
|
| Genotype | 1 | 2020 | 13048 | 0.020 |
Why?
|
| Sirolimus | 1 | 2012 | 1540 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5323 | 0.020 |
Why?
|
| Young Adult | 1 | 2012 | 60110 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 65485 | 0.010 |
Why?
|
| Comorbidity | 1 | 2019 | 10591 | 0.010 |
Why?
|
| Adult | 2 | 2012 | 223818 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 9213 | 0.010 |
Why?
|
| Incidence | 1 | 2023 | 21545 | 0.010 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2006 | 414 | 0.010 |
Why?
|
| Thigh | 1 | 2005 | 239 | 0.010 |
Why?
|
| Lipectomy | 1 | 2005 | 114 | 0.010 |
Why?
|
| Child | 1 | 2012 | 80969 | 0.010 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2007 | 794 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 89247 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2784 | 0.010 |
Why?
|
| Body Patterning | 1 | 2007 | 634 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 14795 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 1895 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2007 | 1564 | 0.010 |
Why?
|
| Epinephrine | 1 | 2005 | 794 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 2005 | 657 | 0.010 |
Why?
|
| Neck | 1 | 2005 | 736 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15471 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2005 | 2108 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3811 | 0.010 |
Why?
|
| Retina | 1 | 2007 | 2661 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2006 | 4178 | 0.010 |
Why?
|
| Anxiety | 1 | 2011 | 4677 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 10486 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2011 | 8541 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 26384 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 17629 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 9081 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 81892 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2006 | 11934 | 0.000 |
Why?
|
| United States | 1 | 2007 | 73180 | 0.000 |
Why?
|